NYSE: CIMChimera Investment Corp Stock
$12.73+0.03 (+0.24%)
Updated Oct 17, 2025
CIM Price
$12.73
Fair Value Price
N/A
Market Cap
$1.03B
52 Week Low
$9.85
52 Week High
$16.05
P/E
9.87x
P/B
0.39x
P/S
3.33x
PEG
0.54x
Dividend Yield
8.72%
Revenue
$339.61M
Earnings
$192.69M
Gross Margin
100%
Operating Margin
57.38%
Profit Margin
31%
Debt to Equity
4.66
Operating Cash Flow
$121M
Beta
1.09
Next Earnings
Nov 5, 2025
Ex-Dividend
Sep 30, 2025
Next Dividend
Oct 31, 2025
CIM Overview
Chimera Investment Corp is a real estate investment trust (REIT) that invests in U.S. government-sponsored agency residential mortgage-backed securities (RMBS), non-agency RMBS, and other real estate-related securities. A significant percentage of the securities are backed by properties in California. The company was incorporated in 2007 and is based in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CIM's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Mortgage REIT
Industry Rating
F
CIM
Ranked#26 of 37
Ranked#26 of 37
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.83 | C | |
| $20.80 | C | |
| $13.22 | C |
Be the first to know about important CIM news, forecast changes, insider trades & much more!
CIM News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CIM scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CIM ($12.73) is trading below its intrinsic value of $16.80, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CIM is good value based on its earnings relative to its share price (9.87x), compared to the US market average (37.42x)
P/E vs Market Valuation
CIM is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CIM due diligence checks available for Premium users.
Valuation
CIM price to earnings (PE)
For valuing profitable companies with steady earnings
Company
9.87x
Industry
3.46x
Market
37.42x
CIM is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CIM is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CIM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.39x
Industry
0.78x
CIM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CIM price to earnings growth (PEG)
For valuing profitable companies with growth potential
CIM is good value based... subscribe to Premium to read more.
PEG Value Valuation
CIM's financial health
Profit margin
Revenue
$71.8M
Net Income
$35.5M
Profit Margin
19.5%
CIM's Earnings (EBIT) of $194.87M... subscribe to Premium to read more.
Interest Coverage Financials
CIM's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$14.9B
Liabilities
$12.2B
Debt to equity
4.66
CIM's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CIM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$7.4M
Investing
-$1.2B
Financing
$1.2B
CIM's operating cash flow ($120.74M)... subscribe to Premium to read more.
Debt Coverage Financials
CIM vs Mortgage REIT Stocks
Chimera Investment Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.